THCT (THC Therapeutics) Shiller PE Ratio: (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is THC Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


THC Therapeutics  (OTCPK:THCT) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


THC Therapeutics Shiller PE Ratio Related Terms


THC Therapeutics Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for THC Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THC Therapeutics Shiller PE Ratio Chart

THC Therapeutics Annual Data
Trend Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

THC Therapeutics Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

THCT vs ZTS, UTHR, NBIX: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


THC Therapeutics Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's Shiller PE Ratio falls into.



THC Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

THC Therapeutics's E10 for the quarter that ended in Jul. 2024 is calculated as:

For example, THC Therapeutics's adjusted earnings per share data for the three months ended in Jul. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jul. 2024 (Change)*Current CPI (Jul. 2024)
=-0.007/314.5400*314.5400
=-0.007

Current CPI (Jul. 2024) = 314.5400.

THC Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201410 -0.164 237.433 -0.217
201501 -0.156 233.707 -0.210
201504 -0.160 236.599 -0.213
201507 -0.020 238.654 -0.026
201510 -0.039 237.838 -0.052
201601 -0.041 236.916 -0.054
201604 -0.067 239.261 -0.088
201607 -0.353 240.628 -0.461
201610 -0.100 241.729 -0.130
201701 0.100 242.839 0.130
201704 -0.003 244.524 -0.004
201707 -0.005 244.786 -0.006
201710 -0.010 246.663 -0.013
201801 -0.010 247.867 -0.013
201804 -0.020 250.546 -0.025
201807 -0.460 252.006 -0.574
201810 -0.030 252.885 -0.037
201901 -0.270 251.712 -0.337
201904 -1.690 255.548 -2.080
201907 0.194 256.571 0.238
201910 -0.010 257.346 -0.012
202001 -0.070 257.971 -0.085
202004 -0.090 256.389 -0.110
202007 0.016 259.101 0.019
202010 -0.004 260.388 -0.005
202101 -0.020 261.582 -0.024
202104 -0.010 267.054 -0.012
202107 -0.050 273.003 -0.058
202110 -0.020 276.589 -0.023
202201 -0.020 281.148 -0.022
202204 -0.020 289.109 -0.022
202207 0.010 296.276 0.011
202210 -0.060 298.012 -0.063
202301 0.050 299.170 0.053
202304 0.003 303.363 0.003
202307 -0.001 305.691 -0.001
202310 -0.002 307.671 -0.002
202401 -0.060 308.417 -0.061
202404 0.003 313.548 0.003
202407 -0.007 314.540 -0.007

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


THC Therapeutics Business Description

Address 203 S Church Steet, Jacksboro, TX, USA, 76458
Website https://thct.io
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.